1088 related articles for article (PubMed ID: 29569955)
1. Placental growth factor reverses decreased vascular and uteroplacental MMP-2 and MMP-9 and increased MMP-1 and MMP-7 and collagen types I and IV in hypertensive pregnancy.
Ren Z; Cui N; Zhu M; Khalil RA
Am J Physiol Heart Circ Physiol; 2018 Jul; 315(1):H33-H47. PubMed ID: 29569955
[TBL] [Abstract][Full Text] [Related]
2. Altered matrix metalloproteinase-2 and -9 expression/activity links placental ischemia and anti-angiogenic sFlt-1 to uteroplacental and vascular remodeling and collagen deposition in hypertensive pregnancy.
Li W; Mata KM; Mazzuca MQ; Khalil RA
Biochem Pharmacol; 2014 Jun; 89(3):370-85. PubMed ID: 24704473
[TBL] [Abstract][Full Text] [Related]
3. TNFα blockade reverses vascular and uteroplacental matrix metalloproteinases imbalance and collagen accumulation in hypertensive pregnant rats.
Ren Z; Cui N; Zhu M; Khalil RA
Biochem Pharmacol; 2021 Nov; 193():114790. PubMed ID: 34600915
[TBL] [Abstract][Full Text] [Related]
4. Increased vascular and uteroplacental matrix metalloproteinase-1 and -7 levels and collagen type I deposition in hypertension in pregnancy: role of TNF-α.
Li W; Cui N; Mazzuca MQ; Mata KM; Khalil RA
Am J Physiol Heart Circ Physiol; 2017 Sep; 313(3):H491-H507. PubMed ID: 28626073
[TBL] [Abstract][Full Text] [Related]
5. Angiogenic imbalance and diminished matrix metalloproteinase-2 and -9 underlie regional decreases in uteroplacental vascularization and feto-placental growth in hypertensive pregnancy.
Dias-Junior CA; Chen J; Cui N; Chiang CL; Zhu M; Ren Z; Possomato-Vieira JS; Khalil RA
Biochem Pharmacol; 2017 Dec; 146():101-116. PubMed ID: 28912068
[TBL] [Abstract][Full Text] [Related]
6. Decreased uterine vascularization and uterine arterial expansive remodeling with reduced matrix metalloproteinase-2 and -9 in hypertensive pregnancy.
Lin C; He H; Cui N; Ren Z; Zhu M; Khalil RA
Am J Physiol Heart Circ Physiol; 2020 Jan; 318(1):H165-H180. PubMed ID: 31834839
[TBL] [Abstract][Full Text] [Related]
7. Decreased homodimerization and increased TIMP-1 complexation of uteroplacental and uterine arterial matrix metalloproteinase-9 during hypertension-in-pregnancy.
Chen J; Ren Z; Zhu M; Khalil RA
Biochem Pharmacol; 2017 Aug; 138():81-95. PubMed ID: 28506758
[TBL] [Abstract][Full Text] [Related]
8. Restoring placental growth factor-soluble fms-like tyrosine kinase-1 balance reverses vascular hyper-reactivity and hypertension in pregnancy.
Zhu M; Ren Z; Possomato-Vieira JS; Khalil RA
Am J Physiol Regul Integr Comp Physiol; 2016 Sep; 311(3):R505-21. PubMed ID: 27280428
[TBL] [Abstract][Full Text] [Related]
9. Placental Growth Factor Administration Abolishes Placental Ischemia-Induced Hypertension.
Spradley FT; Tan AY; Joo WS; Daniels G; Kussie P; Karumanchi SA; Granger JP
Hypertension; 2016 Apr; 67(4):740-7. PubMed ID: 26831193
[TBL] [Abstract][Full Text] [Related]
10. Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fms-like tyrosine kinase-1 expression.
Gilbert JS; Babcock SA; Granger JP
Hypertension; 2007 Dec; 50(6):1142-7. PubMed ID: 17923588
[TBL] [Abstract][Full Text] [Related]
11. EMMPRIN-mediated induction of uterine and vascular matrix metalloproteinases during pregnancy and in response to estrogen and progesterone.
Dang Y; Li W; Tran V; Khalil RA
Biochem Pharmacol; 2013 Sep; 86(6):734-47. PubMed ID: 23856290
[TBL] [Abstract][Full Text] [Related]
12. Placental nitric oxide formation and endothelium-dependent vasodilation underlie pravastatin effects against angiogenic imbalance, hypertension in pregnancy and intrauterine growth restriction.
Chimini JS; Possomato-Vieira JS; da Silva MLS; Dias-Junior CA
Basic Clin Pharmacol Toxicol; 2019 Apr; 124(4):385-393. PubMed ID: 30318719
[TBL] [Abstract][Full Text] [Related]
13. Placental Growth Factor Reduces Blood Pressure in a Uteroplacental Ischemia Model of Preeclampsia in Nonhuman Primates.
Makris A; Yeung KR; Lim SM; Sunderland N; Heffernan S; Thompson JF; Iliopoulos J; Killingsworth MC; Yong J; Xu B; Ogle RF; Thadhani R; Karumanchi SA; Hennessy A
Hypertension; 2016 Jun; 67(6):1263-72. PubMed ID: 27091894
[TBL] [Abstract][Full Text] [Related]
14. Molecular hydrogen ameliorates several characteristics of preeclampsia in the Reduced Uterine Perfusion Pressure (RUPP) rat model.
Ushida T; Kotani T; Tsuda H; Imai K; Nakano T; Hirako S; Ito Y; Li H; Mano Y; Wang J; Miki R; Yamamoto E; Iwase A; Bando YK; Hirayama M; Ohno K; Toyokuni S; Kikkawa F
Free Radic Biol Med; 2016 Dec; 101():524-533. PubMed ID: 27789293
[TBL] [Abstract][Full Text] [Related]
15. Matrix Metalloproteinases in Normal Pregnancy and Preeclampsia.
Chen J; Khalil RA
Prog Mol Biol Transl Sci; 2017; 148():87-165. PubMed ID: 28662830
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D Supplementation Prevents Placental Ischemia Induced Endothelial Dysfunction by Downregulating Placental Soluble FMS-Like Tyrosine Kinase-1.
Ma SL; Tian XY; Wang YQ; Zhang HF; Zhang L
DNA Cell Biol; 2017 Dec; 36(12):1134-1141. PubMed ID: 28981319
[TBL] [Abstract][Full Text] [Related]
17. Sildenafil attenuates placental ischemia-induced hypertension.
George EM; Palei AC; Dent EA; Granger JP
Am J Physiol Regul Integr Comp Physiol; 2013 Aug; 305(4):R397-403. PubMed ID: 23785075
[TBL] [Abstract][Full Text] [Related]
18. Exercise training attenuates placental ischemia-induced hypertension and angiogenic imbalance in the rat.
Gilbert JS; Banek CT; Bauer AJ; Gingery A; Needham K
Hypertension; 2012 Dec; 60(6):1545-51. PubMed ID: 23090773
[TBL] [Abstract][Full Text] [Related]
19. In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies.
Holme AM; Roland MC; Henriksen T; Michelsen TM
Am J Obstet Gynecol; 2016 Dec; 215(6):782.e1-782.e9. PubMed ID: 27503620
[TBL] [Abstract][Full Text] [Related]
20. Hypertension, augmented activity of matrix metalloproteinases-2 and -9 and angiogenic imbalance in hypertensive pregnancy are attenuated by doxycycline.
Nascimento RA; Possomato-Vieira JS; Gonçalves-Rizzi VH; Bonacio GF; Rizzi E; Dias-Junior CA
Eur J Pharmacol; 2018 Dec; 840():60-69. PubMed ID: 30336141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
